Laxmi R. Patil , Naveen Shankarappa Gowda , Rohit N. Maidur , Palaksha Kanive Javaregowda , Mallikarjun Goni , Murigendra.B. Hiremath , Renukaradhya K. Math
{"title":"Profiling of biomarker gene expression pattern in upper GI cancer in southern India","authors":"Laxmi R. Patil , Naveen Shankarappa Gowda , Rohit N. Maidur , Palaksha Kanive Javaregowda , Mallikarjun Goni , Murigendra.B. Hiremath , Renukaradhya K. Math","doi":"10.1016/j.genrep.2025.102305","DOIUrl":null,"url":null,"abstract":"<div><div>Upper gastrointestinal (GI) cancers, including esophageal (EC) and gastric (GC), are highly lethal due to late diagnosis and limited biomarker-driven treatments. This study aimed to assess the expression profiles of selected cancer-associated genes E-cadherin, EGFR, HER2, Ki67, KIF2C, TP53, and PD-L1 in south Indian upper GI cancer patients using qRT-PCR. Gene expression patterns were analysed alongside clinical data and bacterial profiling. The study revealed the upper GI cancer subtype-specific variation in the gene expression pattern. In EC, E-cadherin was variably altered (−4.2 ± 2.3), while EGFR and HER2 showed overall downregulation with interpatient variability. Ki67 (3.4 ± 2.7), KIF2C (3.9 ± 2.9), TP53 (2.7 ± 2.4), and PD-L1 (2.7 ± 2.4) were generally upregulated, indicating enhanced proliferation, genomic instability, and immune modulation. Conversely, GC showed consistent downregulation of all seven genes, suggesting widespread transcriptional suppression and potential immune evasion. Correlation analysis revealed, Ki67-KIF2C and HER2-TP53-E-cadherin emerged as strongly co-expressed gene pairs, hinting coordinated tumor regulation mechanisms. ROC analysis highlighted KIF2C and TP53 as potential diagnostic markers, particularly in EC. Fecal bacterial analysis revealed increased diplococci, notably in GC patients. Clinicopathological correlations showed gene expression variations linked to age, diet, tumor site, and bowel habits. EC reflects active proliferation and immune interaction, whereas GC shows generalized gene suppression. KIF2C and TP53 could be potential diagnostic markers. Findings emphasize the value of integrated molecular and clinical profiling in advancing precision diagnostics for upper GI cancers. Further validation in larger, independent cohorts of multiple sites along with protein-level and functional studies is warranted to confirm the diagnostic utility and biological relevance of the identified biomarkers.</div></div>","PeriodicalId":12673,"journal":{"name":"Gene Reports","volume":"40 ","pages":"Article 102305"},"PeriodicalIF":0.9000,"publicationDate":"2025-07-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Gene Reports","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2452014425001785","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"GENETICS & HEREDITY","Score":null,"Total":0}
引用次数: 0
Abstract
Upper gastrointestinal (GI) cancers, including esophageal (EC) and gastric (GC), are highly lethal due to late diagnosis and limited biomarker-driven treatments. This study aimed to assess the expression profiles of selected cancer-associated genes E-cadherin, EGFR, HER2, Ki67, KIF2C, TP53, and PD-L1 in south Indian upper GI cancer patients using qRT-PCR. Gene expression patterns were analysed alongside clinical data and bacterial profiling. The study revealed the upper GI cancer subtype-specific variation in the gene expression pattern. In EC, E-cadherin was variably altered (−4.2 ± 2.3), while EGFR and HER2 showed overall downregulation with interpatient variability. Ki67 (3.4 ± 2.7), KIF2C (3.9 ± 2.9), TP53 (2.7 ± 2.4), and PD-L1 (2.7 ± 2.4) were generally upregulated, indicating enhanced proliferation, genomic instability, and immune modulation. Conversely, GC showed consistent downregulation of all seven genes, suggesting widespread transcriptional suppression and potential immune evasion. Correlation analysis revealed, Ki67-KIF2C and HER2-TP53-E-cadherin emerged as strongly co-expressed gene pairs, hinting coordinated tumor regulation mechanisms. ROC analysis highlighted KIF2C and TP53 as potential diagnostic markers, particularly in EC. Fecal bacterial analysis revealed increased diplococci, notably in GC patients. Clinicopathological correlations showed gene expression variations linked to age, diet, tumor site, and bowel habits. EC reflects active proliferation and immune interaction, whereas GC shows generalized gene suppression. KIF2C and TP53 could be potential diagnostic markers. Findings emphasize the value of integrated molecular and clinical profiling in advancing precision diagnostics for upper GI cancers. Further validation in larger, independent cohorts of multiple sites along with protein-level and functional studies is warranted to confirm the diagnostic utility and biological relevance of the identified biomarkers.
Gene ReportsBiochemistry, Genetics and Molecular Biology-Genetics
CiteScore
3.30
自引率
7.70%
发文量
246
审稿时长
49 days
期刊介绍:
Gene Reports publishes papers that focus on the regulation, expression, function and evolution of genes in all biological contexts, including all prokaryotic and eukaryotic organisms, as well as viruses. Gene Reports strives to be a very diverse journal and topics in all fields will be considered for publication. Although not limited to the following, some general topics include: DNA Organization, Replication & Evolution -Focus on genomic DNA (chromosomal organization, comparative genomics, DNA replication, DNA repair, mobile DNA, mitochondrial DNA, chloroplast DNA). Expression & Function - Focus on functional RNAs (microRNAs, tRNAs, rRNAs, mRNA splicing, alternative polyadenylation) Regulation - Focus on processes that mediate gene-read out (epigenetics, chromatin, histone code, transcription, translation, protein degradation). Cell Signaling - Focus on mechanisms that control information flow into the nucleus to control gene expression (kinase and phosphatase pathways controlled by extra-cellular ligands, Wnt, Notch, TGFbeta/BMPs, FGFs, IGFs etc.) Profiling of gene expression and genetic variation - Focus on high throughput approaches (e.g., DeepSeq, ChIP-Seq, Affymetrix microarrays, proteomics) that define gene regulatory circuitry, molecular pathways and protein/protein networks. Genetics - Focus on development in model organisms (e.g., mouse, frog, fruit fly, worm), human genetic variation, population genetics, as well as agricultural and veterinary genetics. Molecular Pathology & Regenerative Medicine - Focus on the deregulation of molecular processes in human diseases and mechanisms supporting regeneration of tissues through pluripotent or multipotent stem cells.